These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31630443)

  • 21. Development and psychometric properties of the Functional Assessment of Cancer Therapy-Cutaneous T-Cell Lymphoma (FACT-CTCL).
    Raymundo C; Cella D; Wagner L; Hippe DS; Di M; Guitart J; Rosen ST; Querfeld C; Shinohara MM
    Br J Dermatol; 2024 Jul; ():. PubMed ID: 39078947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis.
    Diamandidou E; Colome-Grimmer M; Fayad L; Duvic M; Kurzrock R
    Blood; 1998 Aug; 92(4):1150-9. PubMed ID: 9694702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of gender, age, race/ethnicity, and stage on quality of life in a spectrum of cutaneous lymphomas.
    Martinez XU; Chowdhury A; Stiller T; Palmer J; Loscalzo M; Barrios E; Abdulla FR; Zain J; Rosen ST; Querfeld C
    Support Care Cancer; 2021 Nov; 29(11):6669-6679. PubMed ID: 33963457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced-stage mycosis fungoides and Sézary syndrome: survival and response to treatment.
    Alberti-Violetti S; Talpur R; Schlichte M; Sui D; Duvic M
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):e105-12. PubMed ID: 25817937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased interleukin-36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome.
    Otobe S; Sugaya M; Nakajima R; Oka T; Takahashi N; Kabasawa M; Miyagaki T; Asano Y; Sato S
    J Dermatol; 2018 Apr; 45(4):468-471. PubMed ID: 29314201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE).
    Wood GS; Tung RM; Haeffner AC; Crooks CF; Liao S; Orozco R; Veelken H; Kadin ME; Koh H; Heald P
    J Invest Dermatol; 1994 Jul; 103(1):34-41. PubMed ID: 8027579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycosis fungoides/Sézary syndrome: report of an unusual case.
    Mehta A; Dhungel BM; Khan MF
    J Cutan Pathol; 2006 Sep; 33 Suppl 2():12-5. PubMed ID: 16972946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mast cells and tryptase are linked to itch and disease severity in mycosis fungoides: Results of a pilot study.
    Terhorst-Molawi D; Lohse K; Ginter K; Puhl V; Metz M; Hu M; Maurer M; Altrichter S
    Front Immunol; 2022; 13():930979. PubMed ID: 36032167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.
    Trautinger F; Knobler R; Willemze R; Peris K; Stadler R; Laroche L; D'Incan M; Ranki A; Pimpinelli N; Ortiz-Romero P; Dummer R; Estrach T; Whittaker S
    Eur J Cancer; 2006 May; 42(8):1014-30. PubMed ID: 16574401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychiatric comorbidity, depression, and anxiety levels and quality of life of the patients with mycosis fungoides.
    Engin B; Keçici AS; Uzun AÖ; Yalçın M
    Dermatol Ther; 2020 Nov; 33(6):e13922. PubMed ID: 32594601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning for mycosis fungoides and Sezary syndrome.
    Shiratori S; Fujimoto K; Nishimura M; Hatanaka KC; Kosugi-Kanaya M; Okada K; Sugita J; Shigematsu A; Hashimoto D; Endo T; Kondo T; Abe R; Hashino S; Matsuno Y; Shimizu H; Teshima T
    Hematol Oncol; 2016 Mar; 34(1):9-16. PubMed ID: 25312300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytomegalovirus seropositivity is significantly associated with mycosis fungoides and Sézary syndrome.
    Herne KL; Talpur R; Breuer-McHam J; Champlin R; Duvic M
    Blood; 2003 Mar; 101(6):2132-6. PubMed ID: 12446446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How I treat mycosis fungoides and Sézary syndrome.
    Whittaker S; Hoppe R; Prince HM
    Blood; 2016 Jun; 127(25):3142-53. PubMed ID: 27151889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factor analysis in mycosis fungoides/Sézary syndrome.
    Diamandidou E; Colome M; Fayad L; Duvic M; Kurzrock R
    J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):914-24. PubMed ID: 10365922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune evasion and current immunotherapy strategies in mycosis fungoides (MF) and Sézary syndrome (SS).
    Shalabi D; Bistline A; Alpdogan O; Kartan S; Mishra A; Porcu P; Nikbakht N
    Chin Clin Oncol; 2019 Feb; 8(1):11. PubMed ID: 30691274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Outcomes of COVID-19 in Mycosis Fungoides and Sezary Syndrome.
    Levy Yurkovski I; Rokach L; Melamed G; Alapi H; Gazit S; Patalon T; Tadmor T
    Acta Haematol; 2023; 146(6):497-504. PubMed ID: 37517402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased expression of squamous cell carcinoma antigen 1 and 2 in mycosis fungoides and Sézary syndrome.
    Oka K; Miyagawa T; Suga H; Miyagaki T; Mizuno Y; Kamijo H; Hisamoto T; Omori I; Boki H; Oka T; Takahashi-Shishido N; Sugaya M; Sato S
    Eur J Dermatol; 2022 Jul; 32(4):464-470. PubMed ID: 36301759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE): Protocol for a Translational Study.
    Belfrage E; Ek S; Johansson Å; Brauner H; Sonesson A; Drott K
    JMIR Res Protoc; 2024 Apr; 13():e55723. PubMed ID: 38436589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.
    Benton EC; Crichton S; Talpur R; Agar NS; Fields PA; Wedgeworth E; Mitchell TJ; Cox M; Ferreira S; Liu P; Robson A; Calonje E; Stefanato CM; Wilkins B; Scarisbrick J; Wain EM; Child F; Morris S; Duvic M; Whittaker SJ
    Eur J Cancer; 2013 Sep; 49(13):2859-68. PubMed ID: 23735705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.